Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Oral Membrane for CINV in Children
NCT06371014Not yet recruiting
- Start
- May 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
01
Overview
Randomised trial of ondansetron in chemotherapy-induced nausea and vomiting (CINV) (2 arms). Primary endpoint: Complete Remission Rates in the Acute Phases. Planned start May 2024; status: not yet recruiting.
02
Drugs
ondansetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT06371014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06371014.